David A. Horwitz, MD, Member of FOCIS

Founder
General Nanotherapeutics, LLC

Poster(s):

• Th61 - The Tolerogenic Effects of IL-2 on T Regulatory Cells (Tregs) are TGF-β Dependent
  Thursday, June 23, 2022

  6:15 PM – 7:30 PM PT